Abstract:Per- and Polyfluoroalkyl Substances (PFAS) bioaccumulate in the human body, presenting potential health risks and cellular toxicity. Their transport mechanisms and interactions with tissues and the circulatory system require further investigation. This study investigates the interaction mechanisms of six PFAS with Human Serum Albumin (HSA) using multi-spectroscopy, DFT and a molecular dynamics approach. Multi-spectral analysis shows that perfluorononanoic acid (PFNA) has the best binding capabilities with HSA. The order of binding constants (298 K) is as follows: "Perfluorononanoic Acid (PFNA, 7.81 × 106 L·mol−1) > Perfluoro-2,5-dimethyl-3,6-dioxanonanoic Acid (HFPO-TA, 3.70 × 106 L·mol−1) > Perfluorooctanoic Acid (PFOA, 2.27 × 105 L·mol−1) > Perfluoro-3,6,9-trioxadecanoic Acid (PFO3DA, 1.59 × 105 L·mol−1) > Perfluoroheptanoic Acid (PFHpA, 4.53 × 103 L·mol−1) > Dodecafluorosuberic Acid (DFSA, 1.52 × 103 L·mol−1)". Thermodynamic analysis suggests that PFNA and PFO3DA's interactions with HSA are exothermic, driven primarily by hydrogen bonds or van der Waals interactions. PFHpA, DFSA, PFOA, and HFPO-TA's interactions with HSA, on the other hand, are endothermic processes primarily driven by hydrophobic interactions. Competitive probe results show that the main HSA–PFAS binding site is in the HSA structure's subdomain IIA. These findings are also consistent with the findings of molecular docking. Molecular dynamics simulation (MD) analysis further shows that the lowest binding energy (−38.83 kcal/mol) is fund in the HSA–PFNA complex, indicating that PFNA binds more readily with HSA. Energy decomposition analysis also indicates that van der Waals and electrostatic interactions are the main forces for the HSA–PFAS complexes. Correlation analysis reveals that DFT quantum chemical descriptors related to electrostatic distribution and characteristics like ESP and ALIE are more representative in characterizing HSA–PFAS binding. This study sheds light on the interactions between HSA and PFAS. It guides health risk assessments and control strategies against PFAS, serving as a critical starting point for further public health research.

Probing the binding interactions between perfluoroalkyl carboxylic acids and adenosine A 2A receptors by spectroscopic techniques, molecular simulations and quantum chemistry

Molecular Simulations on Dynamic Binding of Ibuprofen Onto Site II of Human Serum Albumin: One Potential Way Analysis

Structure-Based Exploration of Sevoflurane Binding Sites in Cognition-Related Synaptotagmin-1

Adenosine A 2A Receptor (A 2A AR) Ligand Screening Using the 19 F-NMR Probe FPPA

19F-NMR studies of the impact of different detergents and nanodiscs on the A2A adenosine receptor

Insights into binding modes of adenosine A2B antagonists with ligand-based and receptor-based methods

Binding Affinity and Mechanism of Six PFAS with Human Serum Albumin: Insights from Multi-Spectroscopy, DFT and Molecular Dynamics Approaches

[Binding Mechanism of Traditional Chinese Medicine Active Component 5-Hydroxymethyl-furfural and HSA or BSA].

Interaction of Perfluoroalkyl Acids with Human Liver Fatty Acid-Binding Protein

Perfluoroalkane sulfonyl fluorides non-covalently bind to human serum albumin at Sudlow's sites

Comparison of A4 and A2a binding sites in striatum and COS cells transfected with adenosine A2a receptors

Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor

Synthesis and biological evaluation of sugar-modified truncated carbanucleosides as A 2A and A 3 adenosine receptor ligands to explore conformational effect to the receptors

Experimental/Computational Study on the Impact of Fluorine on the Structure and Noncovalent Interactions in the Monohydrated Cluster of ortho-Fluorinated 2-Phenylethylamine

Research of Binding Reaction Mechanism for Adenosine in Traditional Chinese Medicine with Serum Albumin

Species differences and mechanism of action of A3 adenosine receptor allosteric modulators

X-ray Crystallography, DFT Calculations and Molecular Docking of Indole-Arylpiperazine Derivatives As Α1a-Adrenoceptor Antagonists

QSAR Analysis of Human Adenosine A3 Receptor Antagonists

Pharmacophore Modeling of Human Adenosine Receptor A2A Antagonists

Comparative Molecular Field Analysis of the Binding of the Stereoisomers of Fenoterol and Fenoterol Derivatives to the Beta2 Adrenergic Receptor.

Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261